Uncategorized

Pfizer Reports Strong Full-Year 2024 Results And Reaffirms 2025 Guidance – Yahoo Finance

  1. Pfizer Reports Strong Full-Year 2024 Results And Reaffirms 2025 Guidance  Yahoo Finance
  2. Pfizer tops earnings estimates as Covid product sales beat expectations and cost cuts pay off  CNBC
  3. Pfizer beats profit estimates on heart disease drug, COVID vaccine sales  Yahoo Finance
  4. Pfizer Earnings: What to Expect and How the Stock Might React  Barron’s
  5. Pfizer stock climbs on Q4 revenue and earnings beat, reaffirmed guidance  MarketWatch